These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20462385)

  • 21. Impact of apoE genotype on oxidative stress, inflammation and disease risk.
    Jofre-Monseny L; Minihane AM; Rimbach G
    Mol Nutr Food Res; 2008 Jan; 52(1):131-45. PubMed ID: 18203129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J; Donkin J; Wellington C
    Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease.
    van Exel E; Eikelenboom P; Comijs H; Frölich M; Smit JH; Stek ML; Scheltens P; Eefsting JE; Westendorp RG
    Arch Gen Psychiatry; 2009 Nov; 66(11):1263-70. PubMed ID: 19884614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach.
    Calabrese V; Scapagnini G; Colombrita C; Ravagna A; Pennisi G; Giuffrida Stella AM; Galli F; Butterfield DA
    Amino Acids; 2003 Dec; 25(3-4):437-44. PubMed ID: 14661103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenomics in Alzheimer's disease.
    Cacabelos R
    Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Alzheimer disease and cholesterol].
    Yanagisawa K
    No To Shinkei; 1999 Feb; 51(2):116-24. PubMed ID: 10198900
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice.
    Yao R; Cheng X; Chen Y; Xie JJ; Yu X; Liao MY; Ding YJ; Tang TT; Liao YH
    Int J Cardiol; 2010 Mar; 139(2):113-22. PubMed ID: 19028402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reduced prevalence of dementia in patients treated with antilipemic agents. An overview of cholesterol metabolism in the brain and actions].
    Carlson LA; Winblad B
    Lakartidningen; 2001 Sep; 98(36):3795-7. PubMed ID: 11586810
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study.
    Roks G; Cruts M; Houwing-Duistermaat JJ; Dermaut B; Serneels S; Havekes LM; Hofman A; Breteler MM; Van Broeckhoven C; van Duijn CM
    Am J Med Genet; 2002 Jul; 114(5):570-3. PubMed ID: 12116196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E as vascular risk factor in neurodegenerative dementia.
    Folin M; Baiguera S; Conconi MT; Di Liddo R; De Carlo E; Parnigotto PP; Nussdorfer GG
    Int J Mol Med; 2004 Oct; 14(4):609-13. PubMed ID: 15375590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alzheimer's disease: new prospects in therapy and applied experimental models].
    Kubis AM; Janusz M
    Postepy Hig Med Dosw (Online); 2008 Aug; 62():372-92. PubMed ID: 18688208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia.
    Paragh G; Balla P; Katona E; Seres I; Egerházi A; Degrell I
    Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):63-7. PubMed ID: 12111338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease.
    Bales KR
    Neuropharmacology; 2010; 59(4-5):295-302. PubMed ID: 20079752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
    He SR; Liu DG; Wang S; Xia YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholesterol and Alzheimer's disease--is there a relation?
    Sjögren M; Mielke M; Gustafson D; Zandi P; Skoog I
    Mech Ageing Dev; 2006 Feb; 127(2):138-47. PubMed ID: 16332384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
    Xu BG; Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease pathogenesis and therapeutic interventions.
    Parihar MS; Hemnani T
    J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOE and cytokines as biological markers for recovery of prevalent delirium in elderly medical inpatients.
    Adamis D; Treloar A; Martin FC; Gregson N; Hamilton G; Macdonald AJ
    Int J Geriatr Psychiatry; 2007 Jul; 22(7):688-94. PubMed ID: 17203511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Alzheimer's disease as neurodegenerative disorder].
    Zabłocka A
    Postepy Hig Med Dosw (Online); 2006; 60():209-16. PubMed ID: 16641890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.